<?xml version="1.0" encoding="UTF-8"?>
<p>Pemphigus vulgaris is a potentially life-threatening autoimmune bullous disease affecting the skin and mucosa and is caused by autoantibodies directed against desmoglein 1 and desmoglein 3 adhesion molecules of the epidermis (
 <xref rid="B3" ref-type="bibr">3</xref>, 
 <xref rid="B4" ref-type="bibr">4</xref>). Severe cases of PV represent a true medical emergency (
 <xref rid="B5" ref-type="bibr">5</xref>). Since the public announcement of the COVID-19 outbreak, several concerns have been raised by dermatologists as well as pemphigus patients who take immunosuppressive drugs. These concerns include the need for proper disease control with minimal immune suppression to avoid possible fatal outcomes. It is also crucial to understand how the underlying mechanisms in COVID-19 (e.g. cytokine release storm leading to interstitial pulmonary inflammation, extensive lung damage and acute respiratory distress syndrome) (
 <xref rid="B6" ref-type="bibr">6</xref>) could affect those auto-immune diseases such as pemphigus.
</p>
